Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000297311 | SCV000477891 | uncertain significance | Amyotrophic Lateral Sclerosis, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001844142 | SCV000477892 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002523744 | SCV003197353 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530479 | SCV004725978 | likely benign | SETX-related disorder | 2023-05-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |